Toxicogenomics: the challenges and opportunities to identify biomarkers, signatures and thresholds to support mode-of-action.

[1]  S. Shen-Orr,et al.  Networks Network Motifs : Simple Building Blocks of Complex , 2002 .

[2]  Russell S. Thomas,et al.  Application of genomic biomarkers to predict increased lung tumor incidence in 2-year rodent cancer bioassays. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[3]  S. Nesnow,et al.  Transcriptional Profiles in Liver from Rats Treated with Tumorigenic and Non-tumorigenic Triazole Conazole Fungicides: Propiconazole, Triadimefon, and Myclobutanil , 2006, Toxicologic pathology.

[4]  Julian L Griffin,et al.  An integrated functional genomic study of acute phenobarbital exposure in the rat , 2010, BMC Genomics.

[5]  Kevin C. Dorff,et al.  The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models , 2010, Nature Biotechnology.

[6]  Elaine Holmes,et al.  Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach. , 2007, Journal of proteome research.

[7]  A. B. Hill.  The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.

[8]  A. Bittner,et al.  Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity , 2006, Molecular carcinogenesis.

[9]  M Younes,et al.  IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. , 2001, Regulatory toxicology and pharmacology : RTP.

[10]  M. F. Shannon,et al.  A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. , 2008, Cancer research.

[11]  Muffy Calder,et al.  The Mammalian MAPK/ERK Pathway Exhibits Properties of a Negative Feedback Amplifier , 2010, Science Signaling.

[12]  Carolyn Vickers,et al.  IPCS framework for analysing the relevance of a cancer mode of action for humans , 2006 .

[13]  D. Moore,et al.  Gadd45β is induced through a CAR‐dependent, TNF‐independent pathway in murine liver hyperplasia , 2005, Hepatology.

[14]  R. Flavell,et al.  Nuclear Receptor CAR Represses TNFα-Induced Cell Death by Interacting with the Anti-Apoptotic GADD45B , 2010, PloS one.

[15]  Jennifer Seed,et al.  A Framework for Human Relevance Analysis of Information on Carcinogenic Modes of Action , 2003, Critical reviews in toxicology.

[16]  R. Iyengar,et al.  From components to regulatory motifs in signalling networks. , 2006, Briefings in functional genomics & proteomics.

[17]  R. Preston,et al.  Application of Key Events Analysis to Chemical Carcinogens and Noncarcinogens , 2009, Critical reviews in food science and nutrition.

[18]  M. Negishi,et al.  The Antiapoptotic Factor Growth Arrest and DNA-Damage-Inducible 45 β Regulates the Nuclear Receptor Constitutive Active/Androstane Receptor-Mediated Transcription , 2008, Drug Metabolism and Disposition.

[19]  P. Watkins,et al.  Quantitative analyses and transcriptomic profiling of circulating messenger RNAs as biomarkers of rat liver injury , 2010, Hepatology.

[20]  L. Burgoon,et al.  The constitutive active/androstane receptor facilitates unique phenobarbital-induced expression changes of genes involved in key pathways in precancerous liver and liver tumors. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[21]  Maqc Consortium.  The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements , 2006, Nature Biotechnology.

[22]  Eduardo Sontag,et al.  Untangling the wires: A strategy to trace functional interactions in signaling and gene networks , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[23]  K. Tomer,et al.  Changes in global gene and protein expression during early mouse liver carcinogenesis induced by non-genotoxic model carcinogens oxazepam and Wyeth-14,643. , 2003, Carcinogenesis.

[24]  H. Ellinger-Ziegelbauer,et al.  Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver. , 2005, Mutation research.

[25]  A. Boobis,et al.  The Key Events Dose-Response Framework: A Cross-Disciplinary Mode-of-Action Based Approach to Examining Dose-Response and Thresholds , 2009, Critical reviews in food science and nutrition.

[26]  M. Fielden,et al.  Interlaboratory evaluation of genomic signatures for predicting carcinogenicity in the rat. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[27]  G. Goodall,et al.  The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.

[28]  Harvey J Clewell,et al.  A method to integrate benchmark dose estimates with genomic data to assess the functional effects of chemical exposure. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[29]  M. Fielden,et al.  A gene expression biomarker provides early prediction and mechanistic assessment of hepatic tumor induction by nongenotoxic chemicals. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[30]  Susan D. Hester,et al.  Transcriptional Profiles in Liver from Mice Treated with Hepatotumorigenic and Nonhepatotumorigenic Triazole Conazole Fungicides: Propiconazole, Triadimefon, and Myclobutanil , 2006, Toxicologic pathology.

[31]  Alan R. Boobis,et al.  IPCS Framework for Analyzing the Relevance of a Cancer Mode of Action for Humans , 2006 .

[32]  Russell S. Thomas,et al.  Application of transcriptional benchmark dose values in quantitative cancer and noncancer risk assessment. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[33]  B. Kholodenko,et al.  Quantification of information transfer via cellular signal transduction pathways , 1997, FEBS letters.

[34]  Jiri Aubrecht,et al.  Inter-laboratory Evaluation of Genomic Signatures for Predicting Carcinogenicity in the Rat Predictive Safety Testing Consortium, Carcinogenicity Working Group , 2008 .

[35]  Mark W. Craven,et al.  Identification of toxicologically predictive gene sets using cDNA microarrays. , 2001, Molecular pharmacology.

[36]  Vincent Bombail,et al.  Gene ontology mapping as an unbiased method for identifying molecular pathways and processes affected by toxicant exposure: application to acute effects caused by the rodent non-genotoxic carcinogen diethylhexylphthalate. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[37]  William Pennie,et al.  Toxicogenomics in risk assessment: an overview of an HESI collaborative research program. , 2004, Environmental health perspectives.

[38]  M. Fielden,et al.  A Gene Expression Signature that Predicts the Future Onset of Drug-Induced Renal Tubular Toxicity , 2005, Toxicologic pathology.

[39]  D. Fell.  Understanding the Control of Metabolism , 1996 .

[40]  Prahlad T. Ram,et al.  Formation of Regulatory Patterns During Signal Propagation in a Mammalian Cellular Network , 2005, Science.

[41]  Pedro Romero,et al.  Toxicogenomics and cancer risk assessment: a framework for key event analysis and dose-response assessment for nongenotoxic carcinogens. , 2010, Regulatory toxicology and pharmacology : RTP.

[42]  H. Ellinger-Ziegelbauer,et al.  Prediction of a carcinogenic potential of rat hepatocarcinogens using toxicogenomics analysis of short-term in vivo studies. , 2008, Mutation research.

[43]  I. Bae,et al.  Gadd45 family proteins are coactivators of nuclear hormone receptors. , 2000, Biochemical and biophysical research communications.

[44]  James J. Chen,et al.  Reproducibility of microarray data: a further analysis of microarray quality control (MAQC) data , 2007, BMC Bioinformatics.

[45]  Christina Kiel,et al.  Cell Type–Specific Importance of Ras–c-Raf Complex Association Rate Constants for MAPK Signaling , 2009, Science Signaling.

[46]  Maqc Consortium.  The MicroArray Quality Control ( MAQC )-II study of common practices for the development and validation of microarray-based predictive models , 2012 .